|
|
Post by brotherm1 on Jun 20, 2017 13:54:55 GMT -5
illegal inside info or much worse? get real
|
|
|
|
Post by uvula on Jun 20, 2017 13:57:40 GMT -5
I'm not an attorney so I should not have made a comment about the legality of posting non-public information. It would be interesting to know how Sax knows something that has not been disclosed.
|
|
|
|
Post by brotherm1 on Jun 20, 2017 14:00:37 GMT -5
ease up You're trying to make an issue out of a non-issue.
|
|
|
|
Post by brotherm1 on Jun 20, 2017 14:06:52 GMT -5
If somebody working for MannKind farts and someone on the outside hears it, it's not non-public or insider information
|
|
|
|
Post by madog365 on Jun 20, 2017 15:13:03 GMT -5
This thread is ridiculous but i will play along with a post i made in another thread:
July is shaping up to be a big month.
Dash Diabetes/Reversed/ DTC Commercial all launching in July?
Matt/Hakan consulting arrangements end in July?
Deerfield 10M loan must be paid in July?
Mannkind officially took Afrezza back last July,2016 so this July will mark 1 full year of 2.0
Is it possible all of this was planned from the start right around the time Mike came over? Was the 1st year just a trial period for something larger?
Why would any company like one drop or biomm partner with a company that's on supposed to be on the verge of insolvency? I don't know but boy is it fun to speculate.
|
|
|
|
Post by matt on Jun 20, 2017 15:32:57 GMT -5
Virtually all executive compensation contracts call for a severance to be paid, either in case the executive is terminated for a reason other than cause or following a change in control. Either one will suffice to get a payout. The way "for cause" is defined in such contracts it is very, very hard to get fired for cause; simply underperforming is not sufficient. Usually the differences are that the change in control (as in a new majority shareholder) all option vesting is accelerated and the payout may be higher. If the options are underwater, there is essentially no difference.
The big announcement coming is how the company has settled with Deerfield. That is the only thing that materially affects the company in the short-term followed by the June 30 earnings announcement due in mid-August. Everything else will take a while to incubate before it affects results.
|
|
|
|
Post by MnkdWASmyRtrmntPlan on Jun 20, 2017 15:37:59 GMT -5
This thread is ridiculous but i will play along with a post i made in another thread: July is shaping up to be a big month. Dash Diabetes/Reversed/ DTC Commercial all launching in July? Matt/Hakan consulting arrangements end in July? Deerfield 10M loan must be paid in July? Mannkind officially took Afrezza back last July,2016 so this July will mark 1 full year of 2.0 Is it possible all of this was planned from the start right around the time Mike came over? Was the 1st year just a trial period for something larger? Why would any company like one drop or biomm partner with a company that's on supposed to be on the verge of insolvency? I don't know but boy is it fun to speculate. I like your speculations, madog. And, why has management been so consistently unconcerned to disregard their impending financial crisis? Sure, that confidence may be a smoke-screen, but my speculation says it's not. |
|
